Colgate-Palmolive (NYSE:CL) Shares Sold by Addison Advisors LLC

Addison Advisors LLC lowered its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 3.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,347 shares of the company’s stock after selling 126 shares during the period. Addison Advisors LLC’s holdings in Colgate-Palmolive were worth $304,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $32,000. Hager Investment Management Services LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $36,000. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive in the third quarter worth about $42,000. Finally, Roxbury Financial LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $43,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.7 %

Shares of CL stock opened at $90.10 on Tuesday. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The firm’s fifty day simple moving average is $88.88 and its 200 day simple moving average is $95.73. The firm has a market capitalization of $73.12 billion, a P/E ratio of 25.60, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm posted $0.87 EPS. As a group, sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.22%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CL. TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Piper Sandler decreased their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Barclays decreased their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, UBS Group reduced their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $101.16.

Check Out Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.